CsA-specific and general side effects during the <i>Medication</i> and “<i>Placebo</i>” condition.
收藏NIAID Data Ecosystem2026-03-09 收录
数据链接：
官方服务：
资源简介：
Treatment groups did not significantly differ in reported CsA-specific and general side effects analyzed with the GASE, neither before study participation (GASE Baseline), nor during the Medication and the “Placebo” condition (all p>0.05). Data are shown as mean ±SEM. CsA-specific and general side effects during the Medication and “Placebo” condition.
创建时间：
2014-09-15
